A detailed history of Laurel Wealth Advisors, Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Laurel Wealth Advisors, Inc. holds 43,668 shares of MRK stock, worth $4.5 Million. This represents 0.48% of its overall portfolio holdings.

Number of Shares
43,668
Previous 44,203 1.21%
Holding current value
$4.5 Million
Previous $3.81 Million 27.27%
% of portfolio
0.48%
Previous 0.41%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

SELL
$87.44 - $112.11 $46,780 - $59,978
-535 Reduced 1.21%
43,668 $4.85 Million
Q3 2022

Nov 14, 2022

SELL
$84.53 - $94.96 $2,028 - $2,279
-24 Reduced 0.05%
44,203 $3.81 Million
Q2 2022

Aug 12, 2022

BUY
$83.49 - $94.64 $54,769 - $62,083
656 Added 1.51%
44,227 $4.03 Million
Q1 2022

May 13, 2022

SELL
$73.51 - $82.4 $208,400 - $233,604
-2,835 Reduced 6.11%
43,571 $3.58 Million
Q4 2021

Feb 14, 2022

BUY
$72.28 - $90.54 $1.75 Million - $2.2 Million
24,273 Added 109.67%
46,406 $3.56 Million
Q3 2021

Nov 12, 2021

SELL
$71.68 - $78.83 $62,648 - $68,897
-874 Reduced 3.8%
22,133 $1.66 Million
Q2 2021

Aug 16, 2021

BUY
$70.31 - $77.77 $23,202 - $25,664
330 Added 1.46%
23,007 $1.79 Million
Q1 2021

May 14, 2021

BUY
$68.86 - $81.11 $86,970 - $102,441
1,263 Added 5.9%
22,677 $1.75 Million
Q4 2020

Mar 03, 2021

BUY
$71.77 - $79.65 $100,406 - $111,430
1,399 Added 6.99%
21,414 $1.75 Million
Q3 2020

Nov 13, 2020

SELL
$73.18 - $82.95 $117,673 - $133,383
-1,608 Reduced 7.44%
20,015 $1.66 Million
Q2 2020

Aug 14, 2020

SELL
$70.42 - $80.13 $51,195 - $58,254
-727 Reduced 3.25%
21,623 $1.67 Million
Q1 2020

May 15, 2020

BUY
$63.36 - $87.82 $37,699 - $52,252
595 Added 2.74%
22,350 $1.72 Million
Q4 2019

Feb 13, 2020

SELL
$77.58 - $87.54 $1.03 Million - $1.17 Million
-13,325 Reduced 37.98%
21,755 $1.98 Million
Q3 2019

Nov 13, 2019

BUY
$76.08 - $82.93 $326,383 - $355,769
4,290 Added 13.93%
35,080 $2.95 Million
Q2 2019

Aug 13, 2019

BUY
$69.84 - $81.59 $3,003 - $3,508
43 Added 0.14%
30,790 $2.58 Million
Q1 2019

May 16, 2019

BUY
$69.58 - $79.36 $45,435 - $51,822
653 Added 2.17%
30,747 $2.56 Million
Q4 2018

Feb 13, 2019

SELL
$65.24 - $75.71 $146,007 - $169,438
-2,238 Reduced 6.92%
30,094 $2.19 Million
Q3 2018

Nov 15, 2018

BUY
$57.69 - $67.84 $88,323 - $103,863
1,531 Added 4.97%
32,332 $2.29 Million
Q2 2018

Aug 20, 2018

BUY
$50.83 - $59.72 $17,892 - $21,021
352 Added 1.16%
30,801 $1.87 Million
Q1 2018

May 16, 2018

BUY
$50.96 - $59.23 $107,219 - $124,619
2,104 Added 7.42%
30,449 $1.66 Million
Q4 2017

Feb 15, 2018

BUY
$51.62 - $61.64 $205,705 - $245,635
3,985 Added 16.36%
28,345 $1.6 Million
Q3 2017

Nov 14, 2017

SELL
$58.67 - $63.13 $5,162 - $5,555
-88 Reduced 0.36%
24,360 $1.56 Million
Q2 2017

Aug 15, 2017

BUY
N/A
24,448
24,448 $1.57 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $261B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Laurel Wealth Advisors, Inc. Portfolio

Follow Laurel Wealth Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Laurel Wealth Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Laurel Wealth Advisors, Inc. with notifications on news.